These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 27185624

  • 21. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K, Sharma S, Dash PK, Parida M.
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [Abstract] [Full Text] [Related]

  • 22. Influenza A(H1N1)pdm09 virus exhibiting enhanced cross-resistance to oseltamivir and peramivir due to a dual H275Y/G147R substitution, Japan, March 2016.
    Takashita E, Fujisaki S, Shirakura M, Nakamura K, Kishida N, Kuwahara T, Shimazu Y, Shimomura T, Watanabe S, Odagiri T, Influenza Virus Surveillance Group of Japan.
    Euro Surveill; 2016 Jun 16; 21(24):. PubMed ID: 27336226
    [Abstract] [Full Text] [Related]

  • 23. Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.
    Abed Y, Pizzorno A, Bouhy X, Boivin G.
    PLoS Pathog; 2011 Dec 16; 7(12):e1002431. PubMed ID: 22174688
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pandemic 2009 H1N1 influenza A virus carrying a Q136K mutation in the neuraminidase gene is resistant to zanamivir but exhibits reduced fitness in the guinea pig transmission model.
    Kaminski MM, Ohnemus A, Staeheli P, Rubbenstroth D.
    J Virol; 2013 Feb 16; 87(3):1912-5. PubMed ID: 23192869
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H275Y neuraminidase mutation.
    Abed Y, Pizzorno A, Boivin G.
    Antimicrob Agents Chemother; 2012 Aug 16; 56(8):4375-80. PubMed ID: 22664977
    [Abstract] [Full Text] [Related]

  • 32. Oseltamivir-zanamivir combination therapy is not superior to zanamivir monotherapy in mice infected with influenza A(H3N2) and A(H1N1)pdm09 viruses.
    Pizzorno A, Abed Y, Rhéaume C, Boivin G.
    Antiviral Res; 2014 May 16; 105():54-8. PubMed ID: 24583158
    [Abstract] [Full Text] [Related]

  • 33. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.
    Antivir Ther; 2010 May 16; 15(8):1151-9. PubMed ID: 21149922
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay.
    Takayama I, Nakauchi M, Fujisaki S, Odagiri T, Tashiro M, Kageyama T.
    J Virol Methods; 2013 Mar 16; 188(1-2):73-5. PubMed ID: 23261798
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
    Baz M, Abed Y, Boivin G.
    Antiviral Res; 2007 May 16; 74(2):159-62. PubMed ID: 17137644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.